Globus Medical Q1 2021 Earnings Report
Key Takeaways
Globus Medical reported a strong start to 2021 with a 19.3% increase in worldwide net sales, reaching $227.3 million. GAAP net income increased by 74.7% to $45.3 million, and non-GAAP adjusted EBITDA reached $81.0 million, marking 35.2% of net sales.
Worldwide net sales increased by 19.3% compared to Q1 2020, totaling $227.3 million.
GAAP net income rose by 74.7% to $45.3 million, representing 19.9% of net sales.
GAAP diluted EPS was $0.44, and non-GAAP diluted EPS was $0.49.
Non-GAAP adjusted EBITDA was $81.0 million, accounting for 35.2% of net sales.
Globus Medical
Globus Medical
Globus Medical Revenue by Segment
Globus Medical Revenue by Geographic Location
Forward Guidance
The company increased full year 2021 net sales guidance from $880 million to $925 million and non-GAAP diluted earnings per share guidance from $1.83 to $1.89.
Revenue & Expenses
Visualization of income flow from segment revenue to net income